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In an epidemiologic study of mortality at the Portsmouth Naval Shipyard (PNS), the Na-
tional Institute for Occupational Safety and Health (NIOSH) found no evidence of excess
deaths due to leukemia or other cancers among workers exposed to low levels ofionizing radia-
tion [1]. In a subsequent analysis, Bross and Driscoll [2] identified excess lung cancer mortality
in PNS workers with lifetime radiation dose of I rem or greater and with more than 15 years'
latency since first radiation exposure. Although that observation may be important and is cur-
rently being examined through case-control analyses, it must be recognized that Bross and
Driscoll extracted their observation from matrices of over 4,000 data cells apparently by
recombination of innumerable possible permutations ofdosage and latency intervals. For that
reason, their finding can be regarded as no more than a suggestion for further study. It certainly
does not represent a proper scientific conclusion. Bross and Driscoll's analysis illustrates the
hazard ofperforming multiple statistical comparisons on complex data sets in the absence ofa
priori hypotheses.
The article "Direct Estimates of Low-Level Radiation Risks . . ." by Irwin D.J.
Bross and Deborah Driscoll [2] failed to provide an accurate history ofthe National
Institute for Occupational Safety and Health's (NIOSH) study ofcancer mortality in
persons with radiation exposure at the Portsmouth Naval Shipyard (PNS), Kittery,
Maine. This communication is intended to clarify several points which Bross and
Driscoll have misconstrued.
NIOSH undertook the investigation of mortality at the Portsmouth Naval
Shipyard (PNS) at the request ofthe Subcommittee on Health and the Environment,
United States House ofRepresentatives. Theobject ofthe investigation was either to
confirm or refute a report by Najarian and Colton which found increases in propor-
tional mortality due to leukemia and to all cancers combined among radiation
workers at PNS [3]. The House Subcommittee recommended that a group of scien-
tists outside NIOSH be established to consult with NIOSH researchers on the con-
duct ofthe study. Here it should be made clear that the function ofthis group was to
provide NIOSH with professional review and additional expertise. It was not
established to be an "oversight" committee. Dr. Bross was one of nine of these con-
sultants. A detailed protocol establishing the hypotheses to be tested and the
epidemiologic methods to be employed was drafted by NIOSH and presented to the
consultants in advance of the study. Each of the consultants had the opportunity to
recommend changes or additions to the protocol, and most, including Dr. Bross,
took advantage of that opportunity. Part of the protocol called for calculation of
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All rights of reproduction in any form reserved.standardized mortality rates for PNS workers by specific causes of death. In accor-
dance with the protocol, NIOSH investigators identified a cohort of over 27,000 cur-
rent and former employees from records maintained by PNS. Current vital status
was determined for 95 percent. Over 9,000 of the individuals in the cohort had been
approved for radiation work at PNS, and annual radiation exposure records for
these persons were assembled. Expected numbers of deaths adjusted for age, sex,
race, and calendar time period were calculated for specific causes of death, for five-
year latency periods, for five-year duration of employment periods, and, in the case
of radiation workers, for specific levels of radiation exposure. All of this work was
completed on time and in strict adherence to the protocol.
We did not find evidence of the previously reported fivefold excess in leukemia
deaths among persons occupationally exposed to radiation [1]. We had a statistical
power greater than 99 percent to observe such an increase. Furthermore, no excess in
mortality due to total malignant neoplasms was observed. (It has since been deter-
mined that the major cause of the discrepancies between the conclusions of the
previous researchers and those of the NIOSH study was misclassification of deaths
in the previous study in regard to radiation exposure history [Colton T, Greenberg
R: personal communication].)
Prior to completion and publication of the final report, we distributed a draft
report to the consultants, including Dr. Bross, as well as to a number of other per-
sons active in the field of radiation epidemiology. We received some minor com-
ments suggesting additional or different analyses, but the reviews were overwhelm-
ingly favorable.
Exercising his function as a consultant, Dr. Bross requested copies of all computer
output generated during the analyses. Included in the material which we sent to Dr.
Bross were matrices of observed and expected deaths by five-year latency and dura-
tion of employment categories, and by radiation dose categories for 83 different
causes of death. With no a priori hypothesis ever having been presented to NIOSH
or any member of the consultants' committee, Dr. Bross compared observed with
expected deaths in those matrices for an indeterminate number of causes, after
recombining the data by various latency periods, duration periods, and radiation ex-
posure levels. While it was legitimate for Dr. Bross to peruse the data by stratifying
in this manner, it is a fundamental principle of statistical analysis that one must
resist drawing conclusions from this sort of unguided exercise [4]. It is essential to
understand that in our matrices there are over 4,000 individual cells, each showing
numbers of observed and expected deaths; these 4,000 cells could have been recom-
bined into countless combinations and permutations. At a confidence level set at 95
percent (i.e., p <0.05), by chance alone, 5 percent of these many permutations
would appear to deviate significantly from the expected. Thus it comes as no sur-
prise that a pattern of excess mortality emerged for deaths due to "malignant
neoplasms of the respiratory system" after the data had been rearranged. Other pat-
terns (some that would indicate excess mortality, others that would indicate deficits)
could also have been developed from the data.
This is not to say that the observation of Bross and Driscoll is unimportant. It is
true that excess mortality from respiratory cancer exists at PNS for persons who at-
tained a radiation dose of1 rem and 15 years' latency. Important questions are
raised by this observation as to whether radiation is causally related, or if higher
levels of radiation correlate with other occupational exposures, such as exposure to
asbestos or to other respiratory carcinogens. The NIOSH protocol had anticipated
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and provided for further evaluations of findings such as this, and, in fact, we are
now performing nested case-control studies within the PNS cohort to look more
closely at mortality from lung cancer as well as from leukemia. NIOSH is near to
completion ofthese case-control studies, and we expect to publish results in the near
future.
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